Rapid development of atypical fibroxanthoma during vismodegib treatment

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and experimental dermatology 2019-01, Vol.44 (1), p.86-88
Hauptverfasser: Giorgini, C., Barbaccia, V., Croci, G. A., Imarisio, I., Vassallo, C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 88
container_issue 1
container_start_page 86
container_title Clinical and experimental dermatology
container_volume 44
creator Giorgini, C.
Barbaccia, V.
Croci, G. A.
Imarisio, I.
Vassallo, C.
description
doi_str_mv 10.1111/ced.13736
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2150299345</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2150299345</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3206-961035d36ff1594de200b8740b51c1818c66048d90198df28dc5181ac1a3bdfe3</originalsourceid><addsrcrecordid>eNp1kM9LwzAUx4Mobk4P_gNS8OShLj-aNDnKnFMYCKLnkCbpzGibmnbT_fdmdjv6Lu_x-LzPgy8A1wjeo1hTbc09IjlhJ2CMCKMpxgSegjEkME-ZIHwELrpuDSEiKKfnYETihEXGx2DxplpnEmO3tvJtbZs-8WWi-l3rtKqS0hXB_6im__S1SswmuGaVbF1Xe2NXrkj6YFW_v7oEZ6WqOnt16BPw8TR_nz2ny9fFy-xhmWqCIUsFQ5BQQ1hZIioyYzGEBc8zWFCkEUdcMwYzbgREgpsSc6NpXCuNFClMackE3A7eNvivje16ufab0MSXEiMKsRAko5G6GygdfNcFW8o2uFqFnURQ7iOTMTL5F1lkbw7GTVHH7ZE8ZhSB6QB8u8ru_jfJ2fxxUP4C_6F0cw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2150299345</pqid></control><display><type>article</type><title>Rapid development of atypical fibroxanthoma during vismodegib treatment</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Giorgini, C. ; Barbaccia, V. ; Croci, G. A. ; Imarisio, I. ; Vassallo, C.</creator><creatorcontrib>Giorgini, C. ; Barbaccia, V. ; Croci, G. A. ; Imarisio, I. ; Vassallo, C.</creatorcontrib><identifier>ISSN: 0307-6938</identifier><identifier>EISSN: 1365-2230</identifier><identifier>DOI: 10.1111/ced.13736</identifier><identifier>PMID: 30132948</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Aged, 80 and over ; Anilides - adverse effects ; Anilides - therapeutic use ; Carcinoma, Basal Cell - drug therapy ; Histiocytoma, Benign Fibrous - chemically induced ; Histiocytoma, Benign Fibrous - pathology ; Humans ; Male ; Pyridines - adverse effects ; Pyridines - therapeutic use ; Skin Neoplasms - chemically induced ; Skin Neoplasms - drug therapy ; Skin Neoplasms - pathology</subject><ispartof>Clinical and experimental dermatology, 2019-01, Vol.44 (1), p.86-88</ispartof><rights>2018 British Association of Dermatologists</rights><rights>Copyright © 2019 British Association of Dermatologists</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3206-961035d36ff1594de200b8740b51c1818c66048d90198df28dc5181ac1a3bdfe3</citedby><cites>FETCH-LOGICAL-c3206-961035d36ff1594de200b8740b51c1818c66048d90198df28dc5181ac1a3bdfe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30132948$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Giorgini, C.</creatorcontrib><creatorcontrib>Barbaccia, V.</creatorcontrib><creatorcontrib>Croci, G. A.</creatorcontrib><creatorcontrib>Imarisio, I.</creatorcontrib><creatorcontrib>Vassallo, C.</creatorcontrib><title>Rapid development of atypical fibroxanthoma during vismodegib treatment</title><title>Clinical and experimental dermatology</title><addtitle>Clin Exp Dermatol</addtitle><subject>Aged, 80 and over</subject><subject>Anilides - adverse effects</subject><subject>Anilides - therapeutic use</subject><subject>Carcinoma, Basal Cell - drug therapy</subject><subject>Histiocytoma, Benign Fibrous - chemically induced</subject><subject>Histiocytoma, Benign Fibrous - pathology</subject><subject>Humans</subject><subject>Male</subject><subject>Pyridines - adverse effects</subject><subject>Pyridines - therapeutic use</subject><subject>Skin Neoplasms - chemically induced</subject><subject>Skin Neoplasms - drug therapy</subject><subject>Skin Neoplasms - pathology</subject><issn>0307-6938</issn><issn>1365-2230</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM9LwzAUx4Mobk4P_gNS8OShLj-aNDnKnFMYCKLnkCbpzGibmnbT_fdmdjv6Lu_x-LzPgy8A1wjeo1hTbc09IjlhJ2CMCKMpxgSegjEkME-ZIHwELrpuDSEiKKfnYETihEXGx2DxplpnEmO3tvJtbZs-8WWi-l3rtKqS0hXB_6im__S1SswmuGaVbF1Xe2NXrkj6YFW_v7oEZ6WqOnt16BPw8TR_nz2ny9fFy-xhmWqCIUsFQ5BQQ1hZIioyYzGEBc8zWFCkEUdcMwYzbgREgpsSc6NpXCuNFClMackE3A7eNvivje16ufab0MSXEiMKsRAko5G6GygdfNcFW8o2uFqFnURQ7iOTMTL5F1lkbw7GTVHH7ZE8ZhSB6QB8u8ru_jfJ2fxxUP4C_6F0cw</recordid><startdate>201901</startdate><enddate>201901</enddate><creator>Giorgini, C.</creator><creator>Barbaccia, V.</creator><creator>Croci, G. A.</creator><creator>Imarisio, I.</creator><creator>Vassallo, C.</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope></search><sort><creationdate>201901</creationdate><title>Rapid development of atypical fibroxanthoma during vismodegib treatment</title><author>Giorgini, C. ; Barbaccia, V. ; Croci, G. A. ; Imarisio, I. ; Vassallo, C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3206-961035d36ff1594de200b8740b51c1818c66048d90198df28dc5181ac1a3bdfe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aged, 80 and over</topic><topic>Anilides - adverse effects</topic><topic>Anilides - therapeutic use</topic><topic>Carcinoma, Basal Cell - drug therapy</topic><topic>Histiocytoma, Benign Fibrous - chemically induced</topic><topic>Histiocytoma, Benign Fibrous - pathology</topic><topic>Humans</topic><topic>Male</topic><topic>Pyridines - adverse effects</topic><topic>Pyridines - therapeutic use</topic><topic>Skin Neoplasms - chemically induced</topic><topic>Skin Neoplasms - drug therapy</topic><topic>Skin Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Giorgini, C.</creatorcontrib><creatorcontrib>Barbaccia, V.</creatorcontrib><creatorcontrib>Croci, G. A.</creatorcontrib><creatorcontrib>Imarisio, I.</creatorcontrib><creatorcontrib>Vassallo, C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>Clinical and experimental dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Giorgini, C.</au><au>Barbaccia, V.</au><au>Croci, G. A.</au><au>Imarisio, I.</au><au>Vassallo, C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rapid development of atypical fibroxanthoma during vismodegib treatment</atitle><jtitle>Clinical and experimental dermatology</jtitle><addtitle>Clin Exp Dermatol</addtitle><date>2019-01</date><risdate>2019</risdate><volume>44</volume><issue>1</issue><spage>86</spage><epage>88</epage><pages>86-88</pages><issn>0307-6938</issn><eissn>1365-2230</eissn><cop>England</cop><pub>Oxford University Press</pub><pmid>30132948</pmid><doi>10.1111/ced.13736</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0307-6938
ispartof Clinical and experimental dermatology, 2019-01, Vol.44 (1), p.86-88
issn 0307-6938
1365-2230
language eng
recordid cdi_proquest_journals_2150299345
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects Aged, 80 and over
Anilides - adverse effects
Anilides - therapeutic use
Carcinoma, Basal Cell - drug therapy
Histiocytoma, Benign Fibrous - chemically induced
Histiocytoma, Benign Fibrous - pathology
Humans
Male
Pyridines - adverse effects
Pyridines - therapeutic use
Skin Neoplasms - chemically induced
Skin Neoplasms - drug therapy
Skin Neoplasms - pathology
title Rapid development of atypical fibroxanthoma during vismodegib treatment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T02%3A51%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rapid%20development%20of%20atypical%20fibroxanthoma%20during%20vismodegib%20treatment&rft.jtitle=Clinical%20and%20experimental%20dermatology&rft.au=Giorgini,%20C.&rft.date=2019-01&rft.volume=44&rft.issue=1&rft.spage=86&rft.epage=88&rft.pages=86-88&rft.issn=0307-6938&rft.eissn=1365-2230&rft_id=info:doi/10.1111/ced.13736&rft_dat=%3Cproquest_cross%3E2150299345%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2150299345&rft_id=info:pmid/30132948&rfr_iscdi=true